Leptospirosis
79 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
79
Total Reports
7
Deaths Reported
890.0%
Death Rate
Active Ingredients
Leptospirosis
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 79
Most Affected Breeds
Retriever - Labrador 7
Crossbred Canine/dog 6
Boxer (German Boxer) 5
Terrier - Yorkshire 3
Shepherd Dog - Australian 3
Terrier - Jack Russell 3
Chihuahua 3
Shepherd Dog - German 2
Terrier (unspecified) 2
Shih Tzu 2
Most Reported Reactions
Vomiting 36
Lethargy (see also Central nervous system depression in 'Neurological') 14
Diarrhoea 14
Facial swelling (see also 'Skin') 9
Hives (see also 'Skin') 8
Anaphylaxis 8
Panting 7
Lethargy (see also Central nervous system depression in Neurological) 7
Anorexia 6
Elevated alanine aminotransferase (ALT) 6
Seizure NOS 5
Lack of efficacy - NOS 5
Outcome Breakdown
Ongoing
33 (41.8%)
Recovered/Normal
29 (36.7%)
Outcome Unknown
10 (12.7%)
Euthanized
4 (5.1%)
Died
3 (3.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.